Veracyte, Inc. (NASDAQ:VCYT – Get Rating) has earned a consensus recommendation of “Moderate Buy” from the nine research firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have assigned a buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $35.17.
Several analysts recently commented on VCYT shares. Needham & Company LLC lifted their price objective on Veracyte from $31.00 to $33.00 and gave the stock a “buy” rating in a report on Thursday, November 3rd. Raymond James decreased their target price on Veracyte from $31.00 to $27.00 and set an “outperform” rating on the stock in a research report on Friday, November 4th. SVB Leerink boosted their price objective on Veracyte from $30.00